Article

Insurance and Drug Spending

Mark V. Pauly

in The Oxford Handbook of the Economics of the Biopharmaceutical Industry

Published in print April 2012 | ISBN: 9780199742998
Published online September 2012 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780199742998.013.0011

Series: Oxford Handbooks

 Insurance and Drug Spending

More Like This

Show all results sharing these subjects:

  • Economics
  • Health, Education, and Welfare
  • Financial Institutions and Services

GO

Show Summary Details

Preview

This article discusses the conceptual, theoretical, and empirical research on insurance coverage for drugs in the context of a comparison with this idealized model. Deviations from it include (but are not limited to) the inability of insurers to determine and make benefit payments based on an objective health state, the absence of uniform predetermined prices, insurance policies that cover only certain products (e.g., drugs) or that take account only of current-period costs, imperfect information for consumers and providers about what the marginal benefits from drugs and other treatments really are, and the possibility of income effects from benefit payments or coverage per se.

Keywords: insurance coverage; drug insurance; benefit payments; insurers

Article.  12962 words. 

Subjects: Economics ; Health, Education, and Welfare ; Financial Institutions and Services

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.